HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

David Bonekamp Selected Research

allogenic effect factor (AEF)

11/2014Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction.
11/2014Assessing liver fibrosis: comparison of arterial enhancement fraction and diffusion-weighted imaging.
11/2012An elevated arterial enhancement fraction is associated with clinical and imaging indices of liver fibrosis and cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


David Bonekamp Research Topics

Disease

3Neoplasms (Cancer)
11/2014 - 12/2008
2Lymphoma (Lymphomas)
12/2015 - 07/2014
2Fibrosis (Cirrhosis)
11/2014 - 11/2012
2Liver Diseases (Liver Disease)
11/2014 - 11/2012
2Liver Cirrhosis (Hepatic Cirrhosis)
11/2014 - 11/2012
1Hepatocellular Carcinoma (Hepatoma)
11/2014
1Giant Lymph Node Hyperplasia (Castleman's Disease)
10/2011
1Glioma (Gliomas)
04/2010
1Glioblastoma (Glioblastoma Multiforme)
04/2010
1Prostatic Neoplasms (Prostate Cancer)
12/2008

Drug/Important Bio-Agent (IBA)

3allogenic effect factor (AEF)IBA
11/2014 - 11/2012
2Methotrexate (Mexate)FDA LinkGeneric
12/2015 - 07/2014
1Biological Markers (Surrogate Marker)IBA
11/2014
1rituximab (Mabthera)FDA Link
07/2014
1tebufenozide (Mimic)IBA
10/2011
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
04/2010
1imatinib (Gleevec)FDA Link
04/2010
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2010

Therapy/Procedure

1Drug Therapy (Chemotherapy)
10/2011
1Oral Administration
04/2010
1Aftercare (After-Treatment)
12/2008